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The tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) stimulated the synthesis of sphingomyelin (CerPCho) 
from a [14C]choline-labelled phosphatidylcholine (PtdCho) pool in NIH 3T3 cells. Maximal stimulation (68%) of CerP- 
Cho synthesis, accompanied by an increase (38%) in its cellular content, required only 2 nM TPA. Higher concentrations 
of TPA (2-100 nM) had progressively less effect on CerPCho synthesis which correlated with increased hydrolysis of 
precursor PtdCho. In ceils transformed with human or mouse A-&carrying retroviruses TPA-stimulated PtdCho hydro- 
lysis, but not CerPCho synthesis, suggesting independent regulation of these processes by the TPA-stimulated signal 
transduction system. 
Phorbol ester; Sphingomyelin synthesis 
1. INTRODUCTION 
Sphingomyelin is a major phospholipid of mam- 
malian cell membranes [l]. Its synthesis occurs by 
the transfer of the phosphorylcholine group from 
PtdCho to ceramide [2-lo], catalyzed by PtdCho: 
ceramide phosphotransferase. The main, although 
not exclusive, site of CerPCho synthesis both in 
fibroblasts and baby hamster kidney cells is the 
plasma membrane [5-g]. This correlates with 
predominant plasma membrane localization of 
CerPCho [ll-131. 
CerPCho and PtdCho show markedly different 
behaviour in bilayer membrane systems. Thus, 
CerPCho increases while PtdCho decreases the 
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viscosity of biological membranes ([I] and 
references therein). In addition, CerPCho has a 
particularly high affinity for cholesterol [ 14-161, 
another membrane rigidifying agent. Furthermore, 
various metabolites of CerPCho appear to have 
important regulatory functions. Notably, 
sphingosine was shown to exhibit multiple 
biological actions including inhibition of PKC [ 171, 
stimulation of PKC-independent phosphorylation 
of EGF receptor [ 181, an increase in the binding af- 
finity of EGF receptor [18], and inhibition of 
thyrotropin-releasing hormone binding to pituitary 
cells [19]. These effects of sphingosine, or its 
derivatives, may be related to various disorders, 
such as Niemann-Pick disease, atherosclerosis and 
certain types of cancer, known to be associated 
with altered sphingolipid metabolism [I]. 
Because of a possible interrelationship between 
PKC and CerPCho metabolism, studies were in- 
itiated to determine if PKC activation might be in- 
volved in regulating the synthesis or degradation of 
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this important lipid. The potent phorbol ester 
12-0-tetradecanoylphorbol-13-acetate (TPA) was 
used to activate PKC within intact cells. This tumor 
promoter binds to and stimulates PKC, the 
primary cellular phorbol ester receptor which 
mediates the effects of TPA [20-221. A second ap- 
proach was to determine CerPC,ha metabolism in 
NIH 3T3 cells transformed with human or mouse 
A-raf carrying retroviruses. Raf genes encode 
cytoplasmically located proteins which possess 
serine/threonine-specific protein kinase activity 
[23-251. Importantly, the c-raf and A-raf proteins 
show significant primary and secondary amino 
acid sequence homology to PKC [26]. In this com- 
munication we have assessed whether TPA treat- 
ment of NIH 3T3 cells modulates CerPCho syn- 
thesis and whether this response is altered in cells 
transformed with A-raf and v-raf. 
2. MATERIALS AND METHODS 
2.1. Materials 
TPA, PtdCho and CerPCho were purchased from Sigma; 
[methyl-‘4C]choline chloride (50 ,Ki/mmol) was from Amer- 
sham. 
2.2. Cell culture 
Untransformed NIH 3T3 clone 7 and its transformed variants 
were used. Transformations were performed with retroviruses 
carrying either human A-raf (NIH 3T3/6A-raf MSV; [26]) or 
mouse A-ruf (NIH 3T3/9iV-raf MSV; [27]) oncogenes. Cells 
were cultured continuously in DMEM medium (Gibco) sup- 
plemented with 10% fetal calf serum, penicillin-streptomycin 
(50 U/ml and 50 pg/ml, respectively), and glutamine (2 mM). 
Cells (passages 16-34) were in the logarithmic growth phase in 
each experiment. 
2.3. Labelling of CerPCho and PtdCho with [‘4C/choline 
Cells were incubated with [methyl-“klcholine (0.1 pCi/ml) 
for 4 h in the absence or presence of varying concentrations of 
TPA. At the end of incubation the 14C label-containing medium 
was removed and 4 ml of chloroform/methanol (1: 1, v/v) was 
added directly to the plates. After 1 min the extracts were 
transferred to glass tubes and the plates washed with a 
chloroform/methanol mixture (4 ml). Phospholipid extraction 
was continued for at least 1 h and then CerPCho and PtdCho 
were separated by thin-layer chromatography as described 
earlier [28,29]. 
2.4. Measurement of CerPCho synthesis and PtdCho 
degradation during the chase period in cells prelabelled 
with ff4C]choline 
In the experiments shown in figs 2 and 3, cells were incubated 
for 24 h with [methyl-“klcholine (0.1 ,Ki/ml), washed twice 
with 5 ml of fresh medium, followed by further incubation (8 h) 
in the presence of 25 mM unlabelled_choline to dilute the en- 
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dogenous free pool of r4C-labelled choline and its nonlipid in- 
termediates. In fig.3, the last 5 h of incubation is considered to 
be the chase period. At the end of the incubation period, cells 
were processed to determine the [‘?I content of phospholipids 
as described above. 
2.5. Measurement of degradation of CerPCho during the chase 
period in cells prelabelled with /‘“Cjserine 
Cells were incubated with [U-‘4C]serine (1 pCi/ml) for 48 h to 
label the sphingosine portion of CerPCho. Cells were washed 
and first incubated for 3 h to eliminate non-lipid [“C]labelled 
intermediates of serine-Cells were washed again, and then rein- 
cubated in the absence or presence of TPA (0.5-100 nM) for 4 h. 
3. RESULTS 
In the continuous presence of [met@/-i4C]- 
choline, radiolabelling of both PtdCho and CerP- 
Cho was stimulated in NIH 3T3 cells exposed to 
TPA (fig.1). In both cases significant effects were 
observed at TPA concentrations as low as 0.5 nM, 
although the labelling of CerPCho was increased to 
a greater extent than that of PtdCho. The most 
likely explanation for this labelling pattern was 
that TPA stimulated CerPCho synthesis, so pulse- 
chase experiments were performed to study this 
possibility. 
Since CerPCho synthesis occurs by an intramem- 
brane mechanism [9], (i.e. membrane-bound 
substrates are preferentially utilized [8,9]), this 
method of radiolabelling with [methyl-‘4C]choline 
seemed to be more suitable than in vitro methods 
using external substrates. However, to utilize 
radiolabelled endogenous PtdCho as a substrate it 
was necessary to first determine the end point of 
the pulse period, i.e. when no further labelling of 
PtdCho occurred. In the case of NIH 3T3 cells, 
replacement of [‘4C]choIine with a high concentra- 
tion of unlabelled choline resulted in a significant 
decrease in PtdCho labelling only after the 3rd 
hour of chase (fig.2). However, during the subse- 
quent 5 h period, when no labelled choline and 
choline intermediates remained in cells (not 
shown), both the decrease in PtdCho labelling and 
the increase in CerPCho synthesis were constant 
(fig.2). 
Under the experimental conditions established in 
fig.2, studies were carried out to determine the ef- 
fect of increasing concentrations of TPA on CerP- 
Cho synthesis in control and A-raf-transformed 
NIH 3T3 cells (fig.3). CerPCho synthesis in NIH 
3T3 was stimulated 36% by TPA at concentrations 
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Fig.1. Stimulatory effect of TPA on the incorporation of 
[‘4C]choline into sphingomyelin and phosphatidylcholine in 
NIH 3T3 cells. Cells were incubated with [methyl-i4C]choline 
for 4 h in the absence or presence of varying concentrations of 
TPA as indicated. Each point represents the mean f SE of three 
determinations of [“4C]choline-labelled CerPCho (O-O) and 
PtdCho (A-A). Similar results were obtained in two other ex- 
periments. 
as low as 0.5 nM (half-maximal effect), while a full 
stimulatory effect (68%) required only 2 nM TPA. 
At concentrations above 2 nM, TPA was either 
without apparent effect (10 nM) or was even in- 
hibitory (100 nM). In NIH 3T3 cells transformed 
with the human A-rafcarrying retrovirus TPA had 
no significant stimulatory effect at low concentra- 
tions but retained its apparent inhibitory effect 
toward CerPCho synthesis at higher concentra- 
tions (fig.3). Similarly, transformation of NIH 3T3 
cells by either mouse A-raf or v-raf carrying 
retroviruses also resulted in the loss of a 
stimulatory effect on CerPCho synthesis by low 
concentrations of TPA, while the inhibitory effect 
(60-70%) of 100 nM TPA was retained (not 
shown). 
If TPA affected only one of the sites of CerPCho 
synthesis then increased labelling of this 
phospholipid might not truly reflect changes in its 
actual cellular content. To quantitate changes in 
the amount of CerPCho, cells were labelled with 
[14C]choline for 48 h to reach a radioisotopic 
equilibrium among various choline intermediates. 
Treatment of these prelabelled cells with 2 nM TPA 
for 4 h increased the amount of CerPCho from 
8.3 f 0.8 to 11.4 f 0.5 nmol/106cells (n=4). In 
contrast, TPA again failed to significantly elevate 
the cellular content of CerPCho in the raf- 
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Fig.2. Continuous increase of incorporation of [r4C]choline into 
sphingomyelin during the chase period in NIH 3T3 cells. Cells 
were pulse-labelled with [methyl-r4C]choline, washed, and rein- 
cubated (chase period) for up to 8 h. Each point represents the 
mean f SE of three determinations. (O-O), CerPCho; (A-A), 
PtdCho. 
transformed cells. These data indicate that stimula- 
tion of synthesis is associated with the observed in- 
crease in the cellular content of CerPCho. 
Several different mechanisms might be con- 
sidered to explain the inhibitory phase of the TPA 
effect on CerPCho synthesis. To examine if TPA 
treatment altered the degradation of CerPCho, 
control and A-raftransformed cells were first 
preincubated with [r4C]serine to equilibrium to 
label the sphingosine portion of CerPCho. The 
half-life time of this labelled CerPCho was deter- 
mined to be 12 and 16 h in the control and 
transformed cells, respectively. Exposure of these 
[r4C]serine-labelled cells to increasing concentra- 
tions (0.5-100 nM) of TPA was found not to alter 
the degradation rate of CerPCho (not shown). In 
another study [30] TPA also failed to stimulate the 
breakdown of CerPCho in GH3 pituitary cells. To 
elucidate further the mechanism of TPA inhibition 
of CerPCho synthesis, cells were incubated with 
[14C]choline for 48 h until radioisotopic equili- 
brium was attained and then the cells were treated 
with 100 nM TPA. As shown in fig.4, TPA en- 
hanced the loss of 14C-labelled PtdCho and 14C- 
labelled CerPCho to a similar extent in both the 
control and raf-transformed cells, during a 6 h 
chase period. In other experiments it was found 
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Fig.3. Concentration-dependent effect of TPA on 
sphingomyelin synthesis in NIH 3T3 and NIH 3T3/6A-raf MSV 
cells. NIH 3T3 (O-O) or NIH 3T3/6A-raf MSV cells (A-A) 
were pulse-labelled with [methyl-‘4C]choline, washed, in- 
cubated for 3 h in the absence of TPA and then for 5 h in the 
presence of varying concentrations of TPA. Each point 
represents the mean k SE of three determinations. Similar 
results were obtained in two other experiments. 
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Fig.4. TPA-induced loss of ‘%Z-label from PtdCho and CerP- 
Cho during the chase period. Both NIH 3T3 (A) and NIH 
3T3/6A-raf MSV (B) cells were labelled with 
[methyl-%]choline for 48 h. Cells were washed, then incubated 
for 3 h at 37°C in cell culture medium, and washed again. Final- 
ly, the washed 14C-labelled cells were further incubated in the 
absence (open symbols) or presence (closed symbols) of 100 nM 
TPA for O-6 h as indicated. Each point represents the mean + 
SE of three determinations of CerPCho (circles) and PtdCho 
(triangles). 
that 2 nM TPA had little effect on PtdCho 
hydrolysis, and that a maximal effect required 
more than 10 nM TPA. These data are compatible 
with a mechanism where a TPA-induced decrease 
of the prelabelled substrate (PtdCho) pool results 
in a proportional decrease in the synthesis of 
radiolabelled product (CerPCho). 
4. DISCUSSION 
The results presented indicate that treatment of 
NIH 3T3 cells with low concentrations of TPA 
stimulates the synthesis of CerPCho. Since PKC is 
the main cellular target of TPA [20], it is likely that 
this stimulatory effect of TPA on CerPCho syn- 
thesis is initially mediated through the activation of 
this protein kinase. The unusual sensitivity of 
CerPCho synthesis to low concentrations of TPA 
suggests that (i) only a small pool, or a special sub- 
type, of PKC may be involved, and that (ii) a 
relatively small increase in diacylglycerol evel, the 
physiological activator of PKC [20,21], may elicit a 
similar response. It is possible that the effect of 
TPA and/or diacylglycerol is self-potentiating, due 
to the concomitant formation of diacylglycerol 
during CerPCho synthesis, and is terminated only 
when other regulatory processes (e.g. substrate loss 
or downregulation of PKC) become dominant. 
While this manuscript was in preparation, 
Wilson et al. [3 l] reported that in neutrophils TPA 
stimulated the synthesis of ceramide and, thereby, 
decreased the amount of free sphingosine. It is 
possible that at a low rate of PtdCho hydrolysis 
(i.e. at 0.5-2 nM TPA) ceramide was the rate 
limiting substrate for CerPCho synthesis in NIH 
3T3 cells. In this case stimulation of ceramide syn- 
thesis could be reflected in a higher rate of CerP- 
Cho synthesis. The mechanism(s) by which the 
level of sphingolipids and their precursors is 
regulated is (are) of obvious interest since sphingo- 
sine and its derivates may be natural inhibitors of 
PKC [17,32] and may also regulate the binding of 
various hormones to their receptors [18,19]. An in- 
teresting aspect of the TPA effect on sphingolipid 
metabolism is that a possible depletion of sphingo- 
sine stores may synergize with diacylglycerol ac- 
tivation of PKC. The significance of these postu- 
lated mechanisms would be that even small in- 
creases in diacylglycerol content could generate a 
relatively large pool of activated PKC molecules, 
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provided that the stimulatory mechanism for CerP- 
Cho synthesis exists. An exception may exist with 
GH3 pituitary cells where TPA does not appear to 
stimulate either the hydrolyis of PtdCho or the syn- 
thesis of CerPCho [30]. On the other hand both 
processes were stimulated in human leukemic 
HL60 cells [33]. 
It is of interest that CerPCho synthesis, ap- 
parently regulated either directly or indirectly 
through activation of PKC, was not stimulated by 
TPA treatment of cells transformed by A-raf or v- 
raf carrying retroviruses. 
c-raf is the cellular homologue of v-raf, the 
transforming gene of the murine sarcoma virus 
3611 [34,35]. The role of the raf oncogene products 
appears to be that of serine/threonine-specific pro- 
tein kinases with sequence homology to PKC 
[21,23-251. In a mechanism similar to that for PKC 
[36-383, oncogenic activation of the c-raf and A- 
raf protein can occur by an amino-terminal trunca- 
tion which removes a putative regulatory region 
[23,25,26]. This suggests that the kinase activity of 
c-raf and A-raf may be modulated by regulatory 
ligands similar to the regulatory properties of 
PKC. 
The results presented in figs 3 and 4 show that 
transformation of NIH 3T3 cells with A-raf or v- 
raf carrying retroviruses negates the ability of TPA 
to enhance CerPCho synthesis. On the other hand, 
raf transformation of NIH 3T3 cells did not 
significantly alter the TPA-stimulated degradation 
of PtdCho. These results suggest a possible inter- 
relationship between PKC and raf kinase to 
regulate biological processes. Further, they in- 
dicate that the raf kinase may alter (either directly 
or indirectly) the metabolism of sphingomyelin and 
other phospholipids as part of the process involved 
in malignant transformation of cells. 
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